EUCTR2011-002867-40-IE
Active, not recruiting
Not Applicable
Comparsion of continuous paravertebral blockade and continuous wound catheter infiltration for analgesia following mastectomy.
ConditionsThis study will involve the administration of levobupivicaine 0.125% and 0.25%, a local anaesthetic agent licensed for this purpose into the paravertebral space and into the surgical wound, to provide postoperative analgesia for adults having a mastecomy. We aim to compare the analgesia efficacy of paravertebral blockade with surgical wound blockade for post operative pain in the first 48 hours.MedDRA version: 14.0Level: LLTClassification code 10054711Term: Postoperative painSystem Organ Class: 10022117 - Injury, poisoning and procedural complicationsTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
DrugsChirocaine
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- This study will involve the administration of levobupivicaine 0.125% and 0.25%, a local anaesthetic agent licensed for this purpose into the paravertebral space and into the surgical wound, to provide postoperative analgesia for adults having a mastecomy. We aim to compare the analgesia efficacy of paravertebral blockade with surgical wound blockade for post operative pain in the first 48 hours.
- Sponsor
- Department of Anaesthesia
- Status
- Active, not recruiting
- Last Updated
- 14 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adults (aged 18\-80\) presenting for elective mastectomy \+ axillary surgery
- •Written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 45
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range 45
Exclusion Criteria
- •Patient refusal
- •Local infection at site of insertion
- •Allergy to amide local anaesthetics, fentanyl, morphine, paracetamol, volatile anaesthetics
- •Concurrent use of MAOIs or within 2 weeks of MAOI use
- •Systemic anticoagulation or coagulopathy
- •Uncontrolled hypertension
- •Uncontrolled Diabetes Mellitus
- •Severe liver or cardiac dysfunction
- •Inability to comprehend pain scoring system
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Comparison of continuous paravertebral blockade (PVB) and continuous thoracic epidural analgesia (TEA) for analgesia following open renal surgeryEUCTR2008-004998-17-IEDepartment of Anaesethesia
Not yet recruiting
Not Applicable
Comparison of Efficacy of Paravertebral Block and Transforaminal Block in Acute Herpes zosterCertain infectious and parasitic diseasesKCT0002090The Catholic University of Korea, Daejeon St. Mary's Hospital210
Completed
Not Applicable
Efficacy of continuous paravertebral blocks in breast surgeryJPRN-UMIN000011610Gifu University Hospital Department of Anesthesiology&Pain Medicine60
Completed
Phase 1
To study the effectiveness of a newer anaesthetic procedure/block i.e. paravertebral block in breast cancer surgeries for pain relief.CTRI/2020/02/023594Karnataka Institute of Medical Sciences Hubballi40
Completed
Not Applicable
Comparison of two methods of paravertebral block for video-assisted thoracoscopic surgery: intrathoracic approach and ultrasound-guided approachNeoplasmsKCT0006471The Catholic University of Korea, Seoul St. Mary's Hospital74